Skip navigation
中文
English
DSpace
CRIS
首頁
單位
研究人員
研究成果檢索
分類瀏覽
單位
研究人員
研究成果檢索
學術出版
幫助
登入
中文
English
NTU Scholars
研究成果檢索
瀏覽 的方式: 關鍵字
???browse.type.item.subject???
跳到:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
排序方式:
升冪
降冪
結果/頁面
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
顯示 32465 到 32484 筆資料,總共 290800 筆
< 上一頁
下一頁 >
b
1
b anodic polarization
1
b cell
1
b cell development
1
b cell differentiation
2
b cell epitope
1
b cell epitope on hepatitis b surface gene
1
b cell lymphoma/leukemia 10; b-cell lymphoma 3 protein; cyclin a; cyclin b1; cyclin d1; cyclin dependent kinase 1; cyclin dependent kinase 2; cyclin dependent kinase 4; cyclin e; dna; gemcitabine; immunoglobulin enhancer binding protein; k ras protein; myc protein; oxaliplatin; protein p21; protein p27; protein tyrosine phosphatase; short hairpin rna; adult; advanced cancer; aged; animal experiment; animal model; article; aspc-1 cell line; bxpc-3 cell line; cancer prognosis; cancer recurrence; cell cycle; cell cycle progression; cell nucleus; cell viability; controlled study; cytoplasm; dna binding; down regulation; drug cytotoxicity; drug potentiation; flank; g1 phase cell cycle checkpoint; g2 phase cell cycle checkpoint; gene silencing; genetic transfection; human; human cell; immunohistochemistry; inhibition kinetics; inoculation; m phase cell cycle checkpoint; major clinical study; male; metastasis potential; middle aged; mouse; nf kb signaling; nonhuman; overall survival; panc-1 cell line; pancreas carcinoma; pancreatectomy; protein expression; protein transport; tumor growth; tumor xenograft; very elderly; wild type; young adult
1
b cell lymphoma/leukemia 10; immunoglobulin enhancer binding protein; antiinfective agent; adult; antibiotic therapy; cancer staging; cell proliferation; diffuse large b cell lymphoma; echography; endoscopic ultrasonography; female; follow up; histology; human; human tissue; immunohistochemistry; letter; major clinical study; male; marginal zone lymphoma; multicenter study; overall survival; prospective study; recurrence free survival; stomach biopsy; stomach lymphoma; stomach mucosa; treatment response; clinical trial; diffuse large b cell lymphoma; lymphoid tissue; marginal zone lymphoma; mucosa; anti-bacterial agents; humans; lymphoid tissue; lymphoma, b-cell, marginal zone; lymphoma, large b-cell, diffuse; mucous membrane; prospective studies
1
b cell translocation gene 3 protein; beta catenin; glycogen synthase kinase 3beta; protein kinase b; protein p53; t cell factor protein; unclassified drug; beta catenin; btg3 protein, human; glycogen synthase kinase 3; glycogen synthase kinase 3 beta; peptide; protein; protein binding; protein kinase b; protein serine threonine kinase; pyruvate dehydrogenase (acetyl-transferring) kinase; animal experiment; animal model; animal tissue; article; carcinogenesis; cell membrane; cell migration; controlled study; enzyme activity; enzyme inhibition; gene overexpression; human; human tissue; in vitro study; male; mouse; nonhuman; priority journal; prostate cancer; protein binding; protein phosphorylation; protein protein interaction; signal transduction; tumor xenograft; u2os cell line; upregulation; amino acid sequence; animal; antagonists and inhibitors; cell proliferation; chemistry; culture technique; disease course; drug screening; enzymology; epithelial mesenchymal transition; metabolism; molecular genetics; neoplasm; pathology; phosphorylation; prostate tumor; tumor cell line; amino acid sequence; animals; beta catenin; cell culture techniques; cell line, tumor; cell membrane; cell proliferation; disease progression; epithelial-mesenchymal transition; glycogen synthase kinase 3; humans; male; mice; molecular sequence data; neoplasms; peptides; phosphorylation; prostatic neoplasms; protein binding; protein-serine-threonine kinases; proteins; proto-oncogene proteins c-akt; signal transduction; xenograft model antitumor assays
1
b cell; cd8 t cell; il-21; t follicular helper cell; lung cancer; neoantigen
1
b cell; clonal diversity; complementary determining region 3 (cdr3); immune repertoire (ir); next-generation sequencing (ngs); renal transplantation
1
b cell; efficacy; esophageal squamous cell carcinoma; immune checkpoint inhibitor; prognosis
1
b cells
2
b class g protein couple receptors
1
b class genes
1
b decay
1
b decay; branching fraction; ss̄ pair
1
b eis
1
b factory
1